Related Experiment Video
Updated: Jun 8, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Efficiency of carcinogenesis: is the mutator phenotype inevitable?
1Department of Oncology Clinical Research, Daiichi Sankyo Pharmaceutical Development, Edison, NJ 08837, USA. eniac1@snip.net
Seminars in Cancer Biology
|October 12, 2010
Summary
Mutator mutations accelerate cancer by increasing mutation rates, supporting the mutator hypothesis. New modeling shows these faster pathways are likely dominant over slower, non-mutator routes to cancer.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Cancer development necessitates multiple oncogenic mutations.
- The mutator hypothesis posits a critical role for mutator mutations in accelerating carcinogenesis.
- Alternative theories suggest cancer arises from normal mutation rates followed by selection, challenging the mutator hypothesis.
Purpose of the Study:
- To resolve the long-standing debate surrounding the mutator hypothesis in carcinogenesis.
- To quantitatively compare the efficiency of mutator versus non-mutator pathways to cancer.
Main Methods:
- Introduction of the concept of 'efficiency' as a metric for comparing carcinogenic mechanisms.
- Application of a novel theoretical approach using focused quantitative modeling.
Main Results:
- Mutator mechanisms were found to be significantly more efficient than non-mutator pathways.
- Quantitative modeling indicates that mutator pathways are likely to predominate in cancer development.
- The study addresses arguments against the mutator hypothesis, including lineage extinction and the additional step requirement.
Conclusions:
- Mutator mechanisms are likely inevitable and predominant in carcinogenesis.
- The efficiency metric and quantitative modeling provide strong support for the mutator hypothesis.
- This study offers a resolution to the controversy surrounding the role of mutator mutations in cancer.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:36Mismatch Repair
Overview
01:18Mutations in Microorganisms
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...